Rachel Chapman recaps her article, “Tube Erosion,” which was written with Matthew Henderson, MD; Dan Arreaza-Kaufman, MD; Jonathan Eisengart, MD; and Mary Qiu, MD, and was featured in the May/June issue of Glaucoma Today. Glaucoma drainage implants can lower IOP and preserve patients’ vision, but the devices carry the risk of tube erosion, a serious complication that requires prompt surgical management. Ms. Chapman reviews the rates of tube erosion, risk factors, strategies for prevention, and techniques for surgical revision.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Emily Schehlein, MD, and H. George Tanaka, MD, to review a real case from his practice involving a patient with glaucoma with a history of SLT and MIGS. Though the patient’s IOP is at target, she is very unhappy with topical medication. The group discusses the importance of quality of life and weighs possible next steps, including drug delivery, repeat SLT, surgical intervention, or continuing as is. Later, the guests find out what Dr. Singh did, and they compare their opinions with the results of a social media poll of GT’s audience.

Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.

I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos. 

Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.

In this episode, two Glaucoma Today contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.

Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Manjool Shah, MD, and Ticiana De Francesco, MD, to review a real case from his practice. They discuss the patient’s treatment history and how it informs which procedures to consider for the future and which ones to rule out. The guests share how they would proceed before finding out what Dr. Singh did and how their colleagues would approach the case, based on results of a social media poll of GT’s audience.

Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of Glaucoma Today. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.

N. Troy Gurney, MD, and Richard K. Lee, MD, PhD, recap their article, “Pearls for Effective Laser Cyclophotocoagulation of the Glaucomatous Eye,” which was featured in a recent issue of Glaucoma Today. They make the case that transscleral cyclophotocoagulation should be considered earlier in the glaucoma treatment algorithm and review the proper technique and indications to maximize effectiveness and minimize complications.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.

This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters. Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration.

Jason Xiao, BS, recaps his article, “Improving the Affordability of Glaucoma Medications,” which was written with Jin Choi, MD; Pathik Amin, OD; Alaina Tarantino, PharmD, BCPS; and Mary Qiu, MD, and featured in the May/June issue of Glaucoma Today. Their article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs.

Which technologies are essential to conducting a thorough examination for new glaucoma patients? And which modalities and softwares are most useful for long-term care? Danica Marrelli, OD, and Anu Laul, OD, compare their approaches to initial encounters with glaucoma patients, swap notes on their preferred methodologies for tracking long-term treatment, and identify areas where primary eye care providers could improve the quality of care.

On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Monica Ertel, MD, and Mark Gallardo, MD, to review a case from Dr. Singh’s practice. The guests share their perspective on a patient with slowly progressive disease and a history of failed trabeculectomy, and they offer their thoughts on IOP goals and potential treatments. Later, the panelists find out how their colleagues would approach the case based on results of a social media poll of GT’s audience.

Jay Patel, MD, recaps his article, “Masqueraders of Normal-Tension Glaucoma,” coauthored with Amanda D. Henderson, MD, and featured in the May/June issue of Glaucoma Today. The article outlines several types of nonglaucomatous optic neuropathy that should be considered in patients with gradually progressive optic neuropathy.

Francesca Cordeiro, MD, PhD, MRCP, FRCOphth, recaps her article, “DARC: From Bench to Bedside,” which was featured in the March/April issue of Glaucoma Today. In her article, she reviews a novel retinal biomarker—the Detection of Apoptosing Retinal Cells (DARC)—and its potential to function as a surrogate endpoint in glaucoma and other neurodegenerative conditions.

David Solá-Del Valle, MD, recaps his article—“Is Glaucoma Policy Short-Sighted?”—which was written with Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; and Henisk Falah, BS, and featured in the March/April issue of Glaucoma Today. In their article, the authors discuss the shortfalls of health care policies that guide glaucoma care and propose redefining innovation to keep an eye on patient access.

Slow down, take a breath, and get back to basics with glaucoma care. Join moderator I. Paul Singh, MD, and panelists Sarah Van Tassel, MD, and Joseph Panarelli, MD, as they review their priorities for their patient encounters in Glaucoma. Which imaging modalities are most effective? How do their workflows function? And, as new patients become returning patients, how can software solutions such as the ZEISS Glaucoma Workplace help keep your clinic flowing smoothly?